BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bravo Vázquez LA, Moreno Becerril MY, Mora Hernández EO, León Carmona GG, Aguirre Padilla ME, Chakraborty S, Bandyopadhyay A, Paul S. The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential. Molecules 2021;27:211. [PMID: 35011442 DOI: 10.3390/molecules27010211] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ko JY, Wang FS, Chen SH, Kuo SJ. Micro Ribonucleic Acid-29a (miR-29a) Antagonist Normalizes Bone Metabolism in Osteogenesis Imperfecta (OI) Mice Model. Biomedicines 2023;11. [PMID: 36831000 DOI: 10.3390/biomedicines11020465] [Reference Citation Analysis]
2 Long Z, Dou P, Cai W, Mao M, Wu R. MiR-181a-5p promotes osteogenesis by targeting BMP3. Aging (Albany NY) 2023;15:734-47. [PMID: 36734882 DOI: 10.18632/aging.204505] [Reference Citation Analysis]
3 Bravo-Vázquez LA, Medina-Ríos I, Márquez-Gallardo LD, Reyes-Muñoz J, Serrano-Cano FI, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review. Dig Dis Sci 2023;68:38-53. [PMID: 35507132 DOI: 10.1007/s10620-022-07516-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Sharma AR, Lee YH, Lee SS. Recent advancements of miRNAs in the treatment of bone diseases and their delivery potential. Curr Res Pharmacol Drug Discov 2023;4:100150. [PMID: 36691422 DOI: 10.1016/j.crphar.2022.100150] [Reference Citation Analysis]
5 Cianferotti L. Osteomalacia Is Not a Single Disease. Int J Mol Sci 2022;23. [PMID: 36499221 DOI: 10.3390/ijms232314896] [Reference Citation Analysis]
6 Fang S, Cao D, Wu Z, Chen J, Huang Y, Shen Y, Gao Z. Circ_0027885 sponges miR‐203‐3p to regulate RUNX2 expression and alleviates osteoporosis progression.. [DOI: 10.21203/rs.3.rs-2205597/v1] [Reference Citation Analysis]
7 Bravo-Vázquez LA, Frías-Reid N, Ramos-Delgado AG, Osorio-Pérez SM, Zlotnik-Chávez HR, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Transl Oncol 2022;27:101579. [PMID: 36332600 DOI: 10.1016/j.tranon.2022.101579] [Reference Citation Analysis]
8 Smout D, Van Craenenbroeck AH, Jørgensen HS, Evenepoel P. MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease. Clin Kidney J 2023;16:408-21. [PMID: 36865016 DOI: 10.1093/ckj/sfac219] [Reference Citation Analysis]
9 Estrada-meza C, Torres-copado A, Loreti González-melgoza L, Ruiz-manriquez LM, De Donato M, Sharma A, Pathak S, Banerjee A, Paul S. Recent insights into the microRNA and long non-coding RNA-mediated regulation of stem cell populations. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03343-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Damle A, Sundaresan R, Rajwade JM, Srivastava P, Naik A. A concise review on implications of silver nanoparticles in bone tissue engineering. Biomaterials Advances 2022;141:213099. [DOI: 10.1016/j.bioadv.2022.213099] [Reference Citation Analysis]
11 Ruiz-manriquez LM, Carrasco-morales O, Sanchez Z EA, Osorio-perez SM, Estrada-meza C, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. Front Genet 2022;13:910733. [DOI: 10.3389/fgene.2022.910733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang L, Lin Y, Zhang X, Shan C. Research progress of exosomes in orthopedics. Front Genet 2022;13:915141. [DOI: 10.3389/fgene.2022.915141] [Reference Citation Analysis]
13 Pauk M, Saito H, Hesse E, Taipaleenmäki H. Muscle and Bone Defects in Metastatic Disease. Curr Osteoporos Rep 2022. [PMID: 35994202 DOI: 10.1007/s11914-022-00741-y] [Reference Citation Analysis]
14 Gao M, Zhang Z, Sun J, Li B, Li Y. The roles of circRNA–miRNA–mRNA networks in the development and treatment of osteoporosis. Front Endocrinol 2022;13:945310. [DOI: 10.3389/fendo.2022.945310] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jiang C, Lin Y, Shan H, Xia W, Pan C, Wang N, Zhou L, Gao Y, Zhou Z, Yu X. miR-146a Protects against Staphylococcus aureus-Induced Osteomyelitis by Regulating Inflammation and Osteogenesis. ACS Infect Dis 2022;8:918-27. [PMID: 35410468 DOI: 10.1021/acsinfecdis.1c00459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jothimani G, Bhatiya M, Pathak S, Paul S, Banerjee A. Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review. Recent Adv Inflamm Allergy Drug Discov 2022;16:5-15. [PMID: 35670340 DOI: 10.2174/2772270816666220606112727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ogunmwonyi I, Adebajo A, Wilkinson JM. The genetic and epigenetic contributions to the development of nutritional rickets. Front Endocrinol (Lausanne) 2022;13:1059034. [PMID: 36619587 DOI: 10.3389/fendo.2022.1059034] [Reference Citation Analysis]